Matinas BioPharma
MTNB • AMEX
Matinas BioPharma is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Jerome D. Jabbour, with a market cap of $3.7M.
CEOJerome D. Jabbour
Market Cap$3.7M
Biotechnology
Healthcare
Employees34.0
Websitematinasbiopharma.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Matinas BioPharma
Date
Tuesday, April 14, 2026 (in 2 months)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for Matinas BioPharma
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | Q3 2025 | -$0.40 | — | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$1.03 | — | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.33 | — | - | — | 10-Q |
| Apr 15, 2025 | Q4 2024 | -$1.68Est: -$0.78 | -115.4% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.85Est: -$1.00 | +15.0% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$1.00Est: -$1.00 | 0.0% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$1.50Est: -$1.50 | 0.0% | - | — | 10-Q |
| Mar 27, 2024 | Q4 2023 | -$1.50Est: $0.00 | — | - | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$1.50Est: -$1.50 | 0.0% | - | — | — |
| Aug 9, 2023 | Q2 2023 | -$1.50Est: -$1.50 | 0.0% | - | — | 10-Q |
| May 10, 2023 | Q1 2023 | -$1.50Est: -$1.50 | 0.0% | $1.1MEst: $300.0K | +265.3% | 10-Q |
| Mar 15, 2023 | Q4 2022 | -$1.00Est: -$1.50 | +33.3% | $1.1MEst: $1.1M | -3.4% | — |